about
Maternal systemic or cord blood inflammation is associated with birth anthropometry in a Tanzanian prospective cohort.Associations between gestational anthropometry, maternal HIV, and fetal and early infancy growth in a prospective rural/semi-rural Tanzanian cohort, 2012-13.Cryptosporidium prevalence and risk factors among mothers and infants 0 to 6 months in rural and semi-rural Northwest Tanzania: a prospective cohort study.Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study.Elevated Hepcidin Is Part of a Complex Relation That Links Mortality with Iron Homeostasis and Anemia in Men and Women with HIV Infection.Iron and infection: effects of host iron status and the iron-regulatory genes haptoglobin and NRAMP1 (SLC11A1) on host-pathogen interactions in tuberculosis and HIV.Iron homeostasis and progression to pulmonary tuberculosis disease among household contacts.Elevated iron status strongly predicts mortality in West African adults with HIV infection.Elevated hepcidin at HIV diagnosis is associated with incident tuberculosis in a retrospective cohort study.Longitudinal analysis of mature breastmilk and serum immune composition among mixed HIV-status mothers and their infants.Breastfeeding-related maternal microchimerism.Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction.Associations between dietary antioxidant intake and oxidative stress in HIV-seropositive and HIV-seronegative men and women.Early childhood tuberculosis in northwestern Tanzania.Breast milk cells trafficking induces microchimerism-mediated immune system maturation in the infant.Complex anemia in tuberculosis: the need to consider causes and timing when designing interventions.Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT): a protocol for a randomised factorial, double-blind, placebo-controlled trial of azithromycin, nitazoxanide and nicotinamide.Iron
P50
Q30275676-AE70B5BB-ED57-45DC-86C7-EE6926295172Q30278448-A47FD7A1-96AB-4E86-94D9-8F222C6B0A01Q34281757-04563568-BB41-40C5-AA20-19D8B292BB70Q34566723-75AFD38E-789C-4615-8752-1C9BB9C01A51Q35640004-DE672F6B-5788-4400-B4B7-9D2684A9F333Q36441608-2E7EF528-2492-4DF9-9AC8-0915E176F068Q38387424-099318CC-C6D1-4F8A-9C86-0256F8664039Q39232721-B605926B-F0F9-4ACA-A768-1480D79E7E02Q39252747-83B290C5-F44F-4A71-B7FB-3B69E55C04ECQ39345982-0B4699DA-958D-4835-AFF9-2A55369AD2FDQ41925633-425C3B01-08F2-486B-B025-0459ACA5EC00Q43419711-08345591-EF57-4B8D-8BA9-E3D8788BD089Q43879463-70C7A792-3A86-422B-87C9-8E3BB8359411Q43938348-5A28DDC8-8340-4A2D-88B5-57DF0AED2A81Q45074553-7605263A-C8CD-4E9B-AFC0-3E517F8BA77BQ46624796-40378B4D-1C16-42F8-B34B-F7A8AC5AABB5Q55632812-0D3FC5F1-10D8-4F87-A142-8F203EF920B5Q56610792-24828177-416C-44CD-B778-4FBE42BC449E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Joann M McDermid
@ast
Joann M McDermid
@nl
Joann M. McDermid
@en
Joann M. McDermid
@es
type
label
Joann M McDermid
@ast
Joann M McDermid
@nl
Joann M. McDermid
@en
Joann M. McDermid
@es
altLabel
J M McDermid
@en
J McDermid
@en
J. M. McDermid
@en
J. McDermid
@en
Joann M McDermid
@en
Joann McDermid
@en
McDermid JM
@en
McDermid
@en
prefLabel
Joann M McDermid
@ast
Joann M McDermid
@nl
Joann M. McDermid
@en
Joann M. McDermid
@es
P106
P1153
13606069900
P31
P496
0000-0002-5829-1897